✦ LIBER ✦

A pilot study of recombinant human TNF and interferon-gamma in four patients with refractory AML

✍ Scribed by Walter Fiedler; Hans-Josef Weh; Dieter K. Hossfeld

Book ID: 114791567
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 225 KB
Volume: 48
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1992.tb00576.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant human interferon-gamma in pa

Recombinant human interferon-gamma in patients with chronic granulomatous disease —European follow up study

✍ R. S. Weening; G. J. Leitz; R. A. Seger 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 414 KB

Pilot study of human recombinant interfe

Pilot study of human recombinant interferon gamma and accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage IIIAB nonsmall cell lung cancer

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Pilot study of human recombinant interfe

Pilot study of human recombinant interferon gamma and accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage IIIA/B nonsmall cell lung cancer

✍ Edward G. Shaw; Richard L. Deming; Edward T. Creagan; Suresh Nair; John Q. Su; R 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 393 KB

A pilot study of sandostatin LAR in comb

A pilot study of sandostatin LAR in combination with human recombinant alpha interferon in treating patients with metastatic neuroendocrine tumors

✍ Oh, David S.; Pisegna, Joseph R. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 195 KB

A phase II study of recombinant human al

A phase II study of recombinant human alpha-interferon in advanced hormone-refractory prostate cancer

✍ Carol M. Van Haelst-Pisani; Ronald L. Richardson; John Su; Jan C. Buckner; Richa 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB 👁 2 views

To determine the efficacy of recombinant human leukocyte alpha-interferon (IFL-RA) in advanced hormone-refractory prostate cancer, the authors treated 40 patients with IFL-RA administered intramuscularly at a dose of 10 x 10' U/m2 three times weekly. Toxicity was substantial and necessitated at leas

A Phase II combination trial with recomb

A Phase II combination trial with recombinant human tumor necrosis factor and gamma interferon in patients with colorectal cancer

✍ Fiedler, W. ;Zeller, W. ;Peimann, C. -J. ;Weh, H. -J. ;Hossfeld, D. K. 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 779 KB